TY  - GEN
AU  - Burchill,S A
AU  - Kinsey,S E
AU  - Picton,S
AU  - Roberts,P
AU  - Pinkerton,C R
AU  - Selby,P
AU  - Lewis,I J
TI  - Minimal residual disease at the time of peripheral blood stem cell harvest in patients with advanced neuroblastoma
SN  - 0098-1532
PY  - 2001///0816
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - therapeutic use
KW  - Biomarkers, Tumor
KW  - genetics
KW  - Child
KW  - Child, Preschool
KW  - Combined Modality Therapy
KW  - Hematopoietic Stem Cell Mobilization
KW  - Hematopoietic Stem Cell Transplantation
KW  - adverse effects
KW  - Humans
KW  - Infant
KW  - Life Tables
KW  - Neoplasm Proteins
KW  - Neoplasm, Residual
KW  - Neoplastic Cells, Circulating
KW  - Neuroblastoma
KW  - blood
KW  - RNA, Messenger
KW  - RNA, Neoplasm
KW  - Remission Induction
KW  - Reverse Transcriptase Polymerase Chain Reaction
KW  - Sensitivity and Specificity
KW  - Survival Analysis
KW  - Transplantation, Autologous
KW  - Treatment Outcome
KW  - Tumor Cells, Cultured
KW  - chemistry
KW  - Tyrosine 3-Monooxygenase
N1  - Publication Type: Evaluation Study; Journal Article; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1002/1096-911X(20010101)36:1<213::AID-MPO1052>3.0.CO;2-9
ER  -